JENNY MINK: Open Payments
NPI 1417425257 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,907 in 63 payments from 31 companies in 2025. Trend: 2023 $1,536 · 2024 $1,561 · 2025 $1,907
Food & beverage: $1,907
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $268 |
| Novartis Pharmaceuticals Corporation | 7 | $185 |
| Janssen Biotech, Inc. | 4 | $171 |
| Merck Sharp & Dohme LLC | 6 | $162 |
| SOBI, INC | 2 | $144 |
| Daiichi Sankyo Inc. | 5 | $135 |
| Regeneron Healthcare Solutions, Inc. | 1 | $112 |
| ABBVIE INC. | 3 | $62 |
| Exelixis Inc. | 2 | $54 |
| PFIZER INC. | 2 | $52 |
Products named: RYBREVANT, Vonjo, IMFINZI, Enhertu, LIBTAYO, Fabhalta, KISQALI, KEYTRUDA.
Industry payments across TN — which companies pay providers there.
